Tandem Diabetes Care Statistics Share Statistics Tandem Diabetes Care has 67.57M
shares outstanding. The number of shares has increased by 1.74%
in one year.
Shares Outstanding 67.57M Shares Change (YoY) 1.74% Shares Change (QoQ) 0.2% Owned by Institutions (%) 99.99% Shares Floating 66.92M Failed to Deliver (FTD) Shares 49 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 10.1M, so 15.19% of the outstanding
shares have been sold short.
Short Interest 10.1M Short % of Shares Out 15.19% Short % of Float 23.35% Short Ratio (days to cover) 4.85
Valuation Ratios The PE ratio is -24.55 and the forward
PE ratio is -17.46.
Tandem Diabetes Care's PEG ratio is
0.43.
PE Ratio -24.55 Forward PE -17.46 PS Ratio 2.51 Forward PS 0.6 PB Ratio 8.96 P/FCF Ratio 472.08 PEG Ratio 0.43
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tandem Diabetes Care.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.93,
with a Debt / Equity ratio of 1.8.
Current Ratio 2.93 Quick Ratio 2.33 Debt / Equity 1.8 Debt / EBITDA -4.78 Debt / FCF 94.83 Interest Coverage -13.37
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $354.79K Profits Per Employee $-36.24K Employee Count 2,650 Asset Turnover 0.97 Inventory Turnover 3.01
Taxes Income Tax 4.16M Effective Tax Rate -4.52%
Stock Price Statistics The stock price has increased by -74.32% in the
last 52 weeks. The beta is 1.47, so Tandem Diabetes Care's
price volatility has been higher than the market average.
Beta 1.47 52-Week Price Change -74.32% 50-Day Moving Average 17.63 200-Day Moving Average 25.21 Relative Strength Index (RSI) 22.47 Average Volume (20 Days) 1,827,803
Income Statement In the last 12 months, Tandem Diabetes Care had revenue of 940.2M
and earned -96.03M
in profits. Earnings per share was -1.47.
Revenue 940.2M Gross Profit 489.57M Operating Income -99.13M Net Income -96.03M EBITDA -99.13M EBIT -99.28M Earnings Per Share (EPS) -1.47
Full Income Statement Balance Sheet The company has 69.23M in cash and 473.56M in
debt, giving a net cash position of -404.33M.
Cash & Cash Equivalents 69.23M Total Debt 473.56M Net Cash -404.33M Retained Earnings -1.05B Total Assets 875.74M Working Capital 363.13M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 24.23M
and capital expenditures -19.23M, giving a free cash flow of 4.99M.
Operating Cash Flow 24.23M Capital Expenditures -19.23M Free Cash Flow 4.99M FCF Per Share 0.08
Full Cash Flow Statement Margins Gross margin is 52.07%, with operating and profit margins of -10.54% and -10.21%.
Gross Margin 52.07% Operating Margin -10.54% Pretax Margin -9.77% Profit Margin -10.21% EBITDA Margin -10.54% EBIT Margin -10.54% FCF Margin 0.53%
Dividends & Yields TNDM does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TNDM is $22,
which is 117.6% higher than the current price. The consensus rating is "Hold".
Price Target $22 Price Target Difference 117.6% Analyst Consensus Hold Analyst Count 15
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 10, 2017. It was a
backward
split with a ratio of 1:10.
Last Split Date Oct 10, 2017 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -0.31 Piotroski F-Score 4
